COLUMBUS, Neb., Oct. 25, 2017 /PRNewswire/ -- BD (Becton,
Dickinson and Company) (NYSE: BDX), a leading global medical
technology company, was joined today by Gov. Pete Ricketts and other state and local leaders
to break ground on a $60 million
upgrade of its Columbus-East facility.
The 69,000 sq. ft. expansion will transform the Columbus-East
facility into the flagship plastic injection molding manufacturing
facility for BD, and it will become one of the largest and most
sophisticated plastic molding plants in the world. The project is
expected to be completed by 2021.
"This is an exciting day for growing the community of
Columbus and the State of Nebraska," said Governor Ricketts.
"BD's $60 million expansion at their
Columbus-East facility is another example of how the industry's
faith in our state can help create new opportunities in our
communities. With facilities in Columbus, Holdrege, and Broken
Bow, BD has been a great partner in growing the Good Life
and we appreciate their ongoing investment in Nebraska."
In addition to Gov. Ricketts, Columbus Mayor Jim
Bulkley and Councilman John
Lohr also offered words of support for the expansion.
Duane Ostdiek, plant manager for the
BD Columbus-West facility highlighted the 50th
anniversary of cannula (metal part of a needle used in a variety of
health care applications) manufacturing at that facility.
Bill Campbell, plant manager of the
BD Columbus-East facility also was present to commemorate the
15th anniversary of the BD Columbus-East plant.
"BD is one of the largest users of plastic injection molded
products in the world, with hundreds of billions of units produced
internally each year," said James
Borzi, executive vice president and chief supply chain
officer of BD. "The new facility will centralize a majority of BD's
North American plastic molding production and will support multiple
business units in the U.S. and around the world."
Laurie Reagan, the plant manager
for the new plastic molding facility, also spoke at the event and
highlighted BD's plans to invest $7
million to retain and retrain its associates for the
different skill sets needed for plastic molding manufacturing or to
facilitate their transfer to its other manufacturing facility in
Columbus or other sites across the
BD network. BD is partnering with Central
Community College to create customized curriculum for its
retraining needs.
In addition to Columbus, BD
also has operations in Holdrege
and Broken Bow, Neb. and employs
approximately 2,500 people across the state. In September 2016, BD announced a $100 million investment in its Holdrege facility to expand its insulin
syringe manufacturing operations.
About BD
BD is a global medical technology company
that is advancing the world of health by improving medical
discovery, diagnostics and the delivery of care. BD leads in
patient and health care worker safety and the technologies that
enable medical research and clinical laboratories. The company
provides innovative solutions that help advance medical research
and genomics, enhance the diagnosis of infectious disease and
cancer, improve medication management, promote infection
prevention, equip surgical and interventional procedures, and
support the management of diabetes. The company partners with
organizations around the world to address some of the most
challenging global health issues. BD has nearly 50,000 associates
across 50 countries who work in close collaboration with customers
and partners to help enhance outcomes, lower health care delivery
costs, increase efficiencies, improve health care safety and expand
access to health. For more information on BD, please visit
bd.com.
Contacts:
|
|
Troy
Kirkpatrick
|
Monique N.
Dolecki
|
BD Public
Relations
|
BD Investor
Relations
|
858.617.2361
|
201.847.5378
|
troy.kirkpatrick@bd.com
|
monique_dolecki@bd.com
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/bd-breaks-ground-on-60-million-expansion-of-nebraska-manufacturing-facility-300543304.html
SOURCE BD (Becton, Dickinson and Company)